Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Tatan Syuflana / AP
An "immunity gene" evolved in populations across Southeast Asia 50,000 years ago to combat leprosy, a new study finds, and 110 million people of Southeast Asian descent carry the gene today.
What it matters: Leprosy still exists — there were 210,000 new cases reported worldwide in 2015. This study could help emerging gene therapy research combat remaining leprosy cases by further exploring the "immunity gene."
How it evolved: Leprosy is a chronic infection of the skin and peripheral nerves. The study, from Cell Reports, showed that a gene mutation produces proteins that bind to molecules from the bacterium that causes leprosy then shows it to the immune system, which destroys the infected cells. The mutation became more common in populations as it conferred protection from the disease.